Purchase Order 75N93024P00956

Award Date 8/6/24
Potential Completion Date 9/30/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Watertown, MA 02472, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,051.62 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Fluent Biosciences Inc., a small disadvantaged business. The contract is for the provision of proprietary biological/reagent products to support NIAID's infectious disease research programs. Fluent Biosciences has also received prior federal grant awards from NIAID and the National Cancer Institute to...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Fluent Biosciences Inc., a small disadvantaged business. The $11,096.49 contract is for the delivery of Fluent RNA Kits in support of infectious disease research programs. Fluent Biosciences has also received federal grants from the National Institutes of Health to develop and commercialize their PIPseq...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $14,701.29 firm fixed price purchase order to Fluent Biosciences Inc., a small disadvantaged business, for the delivery of consumable biological reagent products. The contract, which does not have a set-aside designation, calls for Fluent Biosciences to provide these goods or services over approximately six weeks at their facility in Watertown, Massachusetts....
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $29,824.89 firm fixed price purchase order to Fluent Biosciences Inc., a small disadvantaged biotechnology company, to provide PIPseq RNA kits, Fluent V nuclei isolation kits, and PIPseq V universal upgrade starter kits. This purchase order supports ongoing infectious disease research programs at the NIH's Neuroimmunological Diseases Section. The contract has a completion date...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Standard Biotools Inc., doing business as Fluidigm, a for-profit manufacturer of specialized scientific instruments and reagents. The $42,900.00 firm fixed-price purchase order is for the delivery of GENE EXPRESSION DYNAMIC ARRAY CHIPS, which are likely consumable laboratory products to support NIAID's biomedical research...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Standard Biotools Inc., doing business as Fluidigm, a for-profit manufacturer of scientific instruments and consumables. The $7,968 contract is for the delivery of gene expression assay chips and sample loading kits for use with the Fluidigm Biomark HD system, which supports large-scale PCR testing. This contract is set...
This is a $11,224.90 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Standard Biotools Inc. (doing business as Fluidigm), a for-profit manufacturer of scientific instruments and reagents. The contract is for the delivery of various antibodies with a period of performance ending on May 31, 2018. Standard Biotools is an established federal contractor...
This federal contract award, with ID HHSN272201401223P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor Standard Biotools Inc., doing business as Fluidigm, for $3,055. The contract is for the purchase of unspecified products or services, has a firm fixed-price pricing type, and was not set aside for small businesses. Fluidigm is an established manufacturer of specialized scientific...
This $85,000.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific) on January 25, 2017. The contract, which does not have a set-aside designation, is for the delivery of specialized biotechnology products and services to support NIAID's biomedical research and healthcare initiatives. As a...
This federal contract award, valued at $5,689.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor Standard Biotools Inc., doing business as Fluidigm. The contract is for the provision of "BILLABLE FIELD SERVICE" and a "BIOMARK READER SERIAL# 072" under award HHSN272201400221P, with a completion date of January 20, 2014. Fluidigm is a for-profit manufacturer of specialized...

This is a $14,701.29 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Fluent Biosciences Inc., a small disadvantaged business. The contract is for the provision of proprietary biological/reagent products to support infectious disease research programs. Fluent Biosciences has also received several federal grants totaling over $7 million from the National Institutes of Health to develop and commercialize their PIPseq technology for high-throughput single cell RNA sequencing, circulating tumor DNA monitoring, and other life sciences applications. This contract does not have a set-aside designation.

Generated 8/7/24, 9:31 AM